查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946994

2026年全球息肉切片检查市场报告

Polyp Biopsy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，息肉切片检查市场经历了显着增长，预计将从2025年的13.9亿美元增长到2026年的15亿美元，复合年增长率为8.5%。过去几年成长要素包括消化器官系统癌症和子宫颈癌发病率的上升、内视镜技术的进步、筛检计画的扩展、人们对早期诊断益处的认识不断提高以及专科诊所的增加。

预计未来几年息肉切片检查市场将维持强劲成长，2030年市场规模将达到20.6亿美元，复合年增长率（CAGR）为8.2%。预测期内的成长要素包括人工智慧辅助切片检查手术、微创技术、医院和诊断检查室的广泛应用、与影像和云端平台的整合以及新型切片检查工具的开发。预测期内的主要趋势包括大肠镜切片检查、阴道镜引导下切片检查、食道胃十二指肠镜切片检查、喉镜切片检查和内视镜黏膜切除术（EMR）。

大肠直肠癌发生率的不断上升预计将显着推动息肉切片检查市场的发展。大肠直肠癌是一种发生于大肠或直肠的恶性肿瘤，由结肠内壁上皮细胞异常且不受控制的增生所引起。这种癌症以其侵袭周围组织和转移至身体其他部位的能力而闻名。大肠直肠癌病例的增加主要归因于常见的饮食习惯，例如摄取大量加工食品和膳食纤维摄取量低。这些习惯会导致慢性炎症，破坏肠道菌丛平衡，并促进癌前病变的形成，最终发展为癌症。息肉切片检查在应对这一趋势中发挥关键作用，它能够早期发现异常病变并进行组织学检查，从而实现及时治疗并降低疾病进展的风险。例如，总部位于美国的非营利组织美国癌症协会估计，到2025年，美国将新增107,320例结直肠癌病例和46,950例直肠癌病例，导致约52,900人死亡。因此，大肠直肠癌发生率的上升正在推动对多息肉切片检查手术的需求。

息肉切片检查市场的主要企业正在投资人工智慧 (AI) 辅助检测系统等先进技术，以提高结肠息肉识别的准确性，并实现对有癌症风险病变的早期检测。 AI 辅助检测系统是医疗设备，可即时分析影像数据，检测异常情况并向医务人员提供视觉警报，从而在无需治疗的情况下为临床决策提供支援。例如，2024 年 9 月，总部位于美国的医疗技术公司 Odin Medical Ltd. 与Olympus Corporation合作，推出了基于云端的人工智慧内视镜平台「CADDIE」。 CADDIE 系统可即时分析大肠镜检查影像，识别可能存在大肠息肉的区域，从而帮助临床医生在检查过程中做出更明智的决策。临床评估表明，该系统在不增加检查时间或风险的情况下提高了腺瘤检出率，证明了其在支持早期诊断和改善患者照护方面的有效性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球息肉切片检查市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 生物技术、基因组学和精准医学
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 大肠镜切片检查
    • 阴道镜引导下切片检查
    • 食道胃十二指肠切片检查
    • 喉镜切片检查
    • 内视镜黏膜切除术（EMR）

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 专科诊所
  • 门诊治疗中心
  • 研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球息肉切片检查市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球息肉切片检查市场规模、对比及成长率分析
  • 全球息肉切片检查市场表现：规模与成长，2020-2025年
  • 全球息肉切片检查市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 大肠镜检查、阴道镜引导下切片检查、食道胃十二指肠镜检查
  • 透过技术
  • 内视镜黏膜切除术（EMR）、内视镜黏膜下剥离术（ESD）、常规切片检查
  • 透过使用
  • 结肠癌、消化系统疾病及其他适应症
  • 最终用户
  • 医院、专科诊所
  • 按类型细分：大肠镜检查
  • 诊断性大肠镜检查、治疗性大肠镜检查
  • 按类型细分：阴道镜引导下切片检查
  • 子宫颈、切片检查和切片检查切片检查
  • 依类型细分：食道胃十二指肠镜检查
  • 诊断性食道胃十二指肠镜检查，治疗性食道胃十二指肠镜检查

第十章 区域与国家分析

  • 全球息肉切片检查市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球息肉切片检查市场：按国家/地区、绩效和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 息肉切片检查市场：竞争格局与市场份额，2024 年
  • 息肉切片检查市场：公司估值矩阵
  • 息肉切片检查市场：公司概况
    • Johnson & Johnson（Ethicon）
    • Medtronic plc
    • Medline Industries LP
    • FUJIFILM Holdings Corporation
    • Stryker Corporation

第37章：其他领先和创新企业

  • Becton Dickinson and Company（BD）, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments（Pvt）Ltd., Innovia Medical

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年息肉切片检查市场：提供新机会的国家
  • 2030年息肉切片检查市场：新兴细分市场机会
  • 息肉切片检查市场展望（2030 年）：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MPBIO06_G26Q1

A polyp biopsy is a medical procedure in which a healthcare professional removes a small tissue sample from an abnormal growth, or polyp, on the lining of an organ or body cavity. The sample is examined under a microscope to assess cellular characteristics, detect disease, and support accurate diagnosis and treatment planning. This procedure helps determine the nature of polyps, distinguish between benign and malignant conditions, and provide critical information for guiding clinical management or surveillance strategies.

The primary types of polyp biopsy are colonoscopy, colposcopy-directed biopsy, esophagogastroduodenoscopy, and laryngoscopy. Colonoscopy with polyp biopsy involves inserting a flexible camera (colonoscope) into the colon to visualize the intestinal lining and remove tissue samples for diagnostic evaluation. Techniques include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and conventional biopsy. These procedures are distributed through online channels, retail pharmacies, and other outlets, and are applied in areas such as colorectal cancer and gastrointestinal disorders. End-users include hospitals, diagnostic laboratories, and specialty clinics.

Tariffs have increased the cost of imported biopsy instruments, endoscopic devices, and consumables, affecting hospitals and diagnostic labs in North America and Europe. Segments such as colonoscopy and EMR are most impacted. Positive effects include encouraging domestic manufacturing and technological innovations in cost-effective biopsy instruments.

The polyp biopsy market research report is one of a series of new reports from The Business Research Company that provides polyp biopsy market statistics, including polyp biopsy industry global market size, regional shares, competitors with a polyp biopsy market share, detailed polyp biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the polyp biopsy industry. This polyp biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The polyp biopsy market size has grown strongly in recent years. It will grow from $1.39 billion in 2025 to $1.5 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising prevalence of gastrointestinal and cervical cancers, improvements in endoscopic technologies, increasing screening programs, awareness of early diagnosis benefits, growth of specialty clinics.

The polyp biopsy market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to AI-assisted biopsy procedures, minimally invasive techniques, expansion of hospital and diagnostic laboratory adoption, integration with imaging and cloud platforms, development of novel biopsy tools. Major trends in the forecast period include colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, endoscopic mucosal resection (emr).

The growing prevalence of colorectal cancer is expected to contribute significantly to the expansion of the polyp biopsy market. Colorectal cancer is a malignant condition that develops in the colon or rectum, originating from abnormal and uncontrolled growth of epithelial cells lining the large intestine. This form of cancer is known for its ability to invade nearby tissues and spread to other parts of the body. The increase in colorectal cancer cases is largely attributed to common dietary habits that are high in processed foods and low in fiber. These habits can cause chronic inflammation, disrupt gut microbiota, and encourage the formation of precancerous growths that may eventually become cancerous. Polyp biopsy plays a critical role in addressing this trend by facilitating early detection and histological examination of abnormal lesions, thereby enabling timely treatment and reducing the risk of disease progression. For example, in 2025, the American Cancer Society, a nonprofit organization based in the United States, estimated that there would be 107,320 new cases of colon cancer and 46,950 new cases of rectal cancer in the country, with approximately 52,900 deaths expected as a result. As such, the rising incidence of colorectal cancer is fueling demand for polyp biopsy procedures.

Key companies in the polyp biopsy market are investing in advanced technologies such as artificial intelligence-assisted detection systems to improve the identification of colorectal polyps and enable earlier recognition of potentially cancerous lesions. An artificial intelligence-assisted detection system is a medical tool that evaluates imaging data in real time to detect abnormalities and generate visual alerts for healthcare providers, assisting them in making informed clinical decisions without delivering therapeutic treatments. For example, in September 2024, Odin Medical Ltd., a medical technology firm based in the United States and affiliated with Olympus Corporation, introduced CADDIE, a cloud-based artificial intelligence endoscopy platform. The CADDIE system analyzes colonoscopy footage in real time, identifying areas that may contain colorectal polyps and allowing clinicians to make better decisions during the examination. Clinical evaluations showed that the system improves the rate of adenoma detection without increasing the time or risk involved in the procedure, demonstrating its effectiveness in supporting early diagnosis and improving patient care.

In October 2024, Caldera Medical, a medical device manufacturer based in the United States, acquired UVision360, Inc. for an undisclosed amount. Through this acquisition, Caldera Medical gains access to UVision360's advanced hysteroscopy technology, including the LUMINELLE Bx system, which enhances the company's offerings in minimally invasive diagnostic and treatment options for uterine conditions such as polyps, fibroids, and other intrauterine abnormalities. UVision360 is a company based in the United States that develops hysteroscopy and cystoscopy systems, including the LUMINELLE platform.

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the polyp biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The polyp biopsy market consists of revenues earned by entities by providing services such as endoscopic ultrasound (EUS), capsule endoscopy, double-balloon enteroscopy, single-balloon enteroscopy, push enteroscopy, transnasal endoscopy, and transanal endoscopic microsurgery (TEM). The market value includes the value of related goods sold by the service provider or included within the service offering. The polyp biopsy market also includes sales of hot biopsy forceps, cold biopsy forceps, endoscopic snares, polypectomy snares, cytology brushes, biopsy needles (fine-needle aspiration needles, core biopsy needles), and endoscopic ultrasound needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polyp Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses polyp biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polyp biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polyp biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Colonoscopy; Colposcopy-Directed Biopsy; Esophagogastroduodenoscopy
  • 2) By Technique: Endoscopic Mucosal Resection (EMR); Endoscopic Submucosal Dissection (ESD); Conventional Biopsy
  • 3) By Application: Colorectal Cancer; Gastrointestinal Disorders; Other Applications
  • 4) By End-User: Hospitals; Specialty Clinics
  • Subsegments:
  • 1) By Colonoscopy: Diagnostic Colonoscopy; Therapeutic Colonoscopy
  • 2) By Colposcopy-Directed Biopsy: Cervical Biopsy; Vaginal Biopsy; Vulvar Biopsy
  • 3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy; Therapeutic Esophagogastroduodenoscopy
  • Companies Mentioned: Johnson & Johnson (Ethicon); Medtronic plc; Medline Industries LP; FUJIFILM Holdings Corporation; Stryker Corporation; Becton Dickinson and Company (BD); Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; STERIS plc; Hologic Inc.; CooperSurgical Inc.; KARL STORZ SE & Co. KG; Cook Medical; ConMed Corporation; Ambu A/S; Richard Wolf GmbH; INRAD; Acheron Instruments (Pvt) Ltd.; Innovia Medical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Polyp Biopsy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Polyp Biopsy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Polyp Biopsy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Polyp Biopsy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Colonoscopy Biopsy
    • 4.2.2 Colposcopy-Directed Biopsy
    • 4.2.3 Esophagogastroduodenoscopy Biopsy
    • 4.2.4 Laryngoscopy Biopsy
    • 4.2.5 Endoscopic Mucosal Resection (Emr)

5. Polyp Biopsy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Specialty Clinics
  • 5.4 Ambulatory Care Centers
  • 5.5 Research Institutes

6. Polyp Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Polyp Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Polyp Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Polyp Biopsy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Polyp Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Polyp Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Polyp Biopsy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Polyp Biopsy Market Segmentation

  • 9.1. Global Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy
  • 9.2. Global Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy
  • 9.3. Global Polyp Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Colorectal Cancer, Gastrointestinal Disorders, Other Applications
  • 9.4. Global Polyp Biopsy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics
  • 9.5. Global Polyp Biopsy Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Colonoscopy, Therapeutic Colonoscopy
  • 9.6. Global Polyp Biopsy Market, Sub-Segmentation Of Colposcopy-Directed Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy
  • 9.7. Global Polyp Biopsy Market, Sub-Segmentation Of Esophagogastroduodenoscopy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

10. Polyp Biopsy Market Regional And Country Analysis

  • 10.1. Global Polyp Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Polyp Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Polyp Biopsy Market

  • 11.1. Asia-Pacific Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Polyp Biopsy Market

  • 12.1. China Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Polyp Biopsy Market

  • 13.1. India Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Polyp Biopsy Market

  • 14.1. Japan Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Polyp Biopsy Market

  • 15.1. Australia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Polyp Biopsy Market

  • 16.1. Indonesia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Polyp Biopsy Market

  • 17.1. South Korea Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Polyp Biopsy Market

  • 18.1. Taiwan Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Polyp Biopsy Market

  • 19.1. South East Asia Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Polyp Biopsy Market

  • 20.1. Western Europe Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Polyp Biopsy Market

  • 21.1. UK Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Polyp Biopsy Market

  • 22.1. Germany Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Polyp Biopsy Market

  • 23.1. France Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Polyp Biopsy Market

  • 24.1. Italy Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Polyp Biopsy Market

  • 25.1. Spain Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Polyp Biopsy Market

  • 26.1. Eastern Europe Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Polyp Biopsy Market

  • 27.1. Russia Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Polyp Biopsy Market

  • 28.1. North America Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Polyp Biopsy Market

  • 29.1. USA Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Polyp Biopsy Market

  • 30.1. Canada Polyp Biopsy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Polyp Biopsy Market

  • 31.1. South America Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Polyp Biopsy Market

  • 32.1. Brazil Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Polyp Biopsy Market

  • 33.1. Middle East Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Polyp Biopsy Market

  • 34.1. Africa Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Polyp Biopsy Market, Segmentation By Type, Segmentation By Technique, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Polyp Biopsy Market Regulatory and Investment Landscape

36. Polyp Biopsy Market Competitive Landscape And Company Profiles

  • 36.1. Polyp Biopsy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Polyp Biopsy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Polyp Biopsy Market Company Profiles
    • 36.3.1. Johnson & Johnson (Ethicon) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Polyp Biopsy Market Other Major And Innovative Companies

  • Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

38. Global Polyp Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Polyp Biopsy Market

40. Polyp Biopsy Market High Potential Countries, Segments and Strategies

  • 40.1 Polyp Biopsy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Polyp Biopsy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Polyp Biopsy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer